2144-0834 Screening compound: 4-[(2E)-2-{[2-(benzyloxy)-5-bromophenyl]methylidene}hydrazin-1-yl]-N-(2,3-dimethylphenyl)-6-(4-methylpiperidin-1-yl)-1,3,5-triazin-2-amine

2144-0834 Screening compound: 4-[(2E)-2-{[2-(benzyloxy)-5-bromophenyl]methylidene}hydrazin-1-yl]-N-(2,3-dimethylphenyl)-6-(4-methylpiperidin-1-yl)-1,3,5-triazin-2-amine
2144-0834 Screening compound: 4-[(2E)-2-{[2-(benzyloxy)-5-bromophenyl]methylidene}hydrazin-1-yl]-N-(2,3-dimethylphenyl)-6-(4-methylpiperidin-1-yl)-1,3,5-triazin-2-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound 2144-0834
4-[(2E)-2-{[2-(benzyloxy)-5-bromophenyl]methylidene}hydrazin-1-yl]-N-(2,3-dimethylphenyl)-6-(4-methylpiperidin-1-yl)-1,3,5-triazin-2-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2144-0834

Molecular Formula

C31H34BrN7O (C31 H34 BrN7 O)

Compound Name

4-[(2E)-2-{[2-(benzyloxy)-5-bromophenyl]methylidene}hydrazin-1-yl]-N-(2,3-dimethylphenyl)-6-(4-methylpiperidin-1-yl)-1,3,5-triazin-2-amine

IUPAC name

4-[(2E)-2-{[2-(benzyloxy)-5-bromophenyl]methylidene}hydrazin-1-yl]-N-(23-dimethylphenyl)-6-(4-methylpiperidin-1-yl)-135-triazin-2-amine

SMILES

CC(CC1)CCN1c1nc(Nc2c(C)c(C)ccc2)nc(N/N=C/c(cc(cc2)Br)c2OCc2ccccc2)n1

InChI

InChI=1S/C31H34BrN7O/c1-21-14-16-39(17-15-21)31-36-29(34-27-11-7-8-22(2)23(27)3)35-30(37-31)38-33-19-25-18-26(32)12-13-28(25)40-20-24-9-5-4-6-10-24/h4-13,18-19,21H,14-17,20H2,1-3H3,(H2,34,35,36,37,38)

InChI Key

AOLXQTOWWLBAJS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01065957

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

600.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

10.019

Distribution Coefficient, logD

10.018

Water Solubility, LogSw

-5.91

Polar Surface Area

71.418

Acid Dissociation Constant (pKa)

12.18

Base Dissociation Constant (pKb)

5.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.00

2144-0834 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with 2144-0834 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2144-0834?
Check Price and Availability of 2144-0834, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2144-0834 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2144-0834
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2144-0834
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2144-0834 available by request